Type 1 Diabetes Management in Developing Countries

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas, leading to a lifelong dependence on exogenous insulin. Managing T1D is a complex and multifaceted challenge, encompassing prevention, screening, diagnosis, and ongoing care. This chapter provides an overview of the management of T1D, with a particular focus on the context of developing countries. In developing countries, the management of T1D faces unique challenges, including limited access to healthcare resources, financial barriers, and insufficient infrastructure. However, significant achievements have been made in recent years, driven by global initiatives and the concerted efforts of healthcare providers, governments, non-governmental organizations (NGOs), and individuals with T1D. Prevention and early detection are critical components of T1D management. Genetic screening, newborn screening programs, and public health campaigns play pivotal roles in identifying at-risk individuals and facilitating timely interventions. Accurate diagnosis through autoantibody testing and C-peptide measurements allows for appropriate treatment initiation. Effective T1D management extends beyond diagnosis to encompass ongoing care. This includes patient education, access to insulin and supplies, psychosocial support, and the prevention of diabetes-related complications. Telemedicine and online resources have emerged as valuable tools in bridging healthcare gaps, providing education, and enabling remote monitoring in both developed and developing countries.